n the cities clustered along Colorado’s Front Range, research universities, federal laboratories, startups, and established companies operate within easy reach. That closeness matters. It encourages collaboration early and often in a community known for wel coming new ideas and new arrivals. Colorado’s leadership in quantum, aero space, climate technology, and other research-intensive industries expands possibilities for life sciences. Here, people shaping the future are close enough to shape it together. Renovare Therapeutics Pioneers Regenerative Joint Treatments The Renovare Therapeutics team sees a future with less pain, restored mobility, and improved quality of life for the 32 million Americans and more than 500 million people worldwide living with osteoarthritis. “Patients often spend a decade living with pain that takes away the activities, inde pendence, and identity they love,” says Liz Scott, Chief Executive Officer of Renovare Therapeutics. “We’re not interested in slowing the progression of disease; we’re trying to reverse the damage by prompting the body to regenerate cartilage and bone.” The science is bold, and the federal funding model behind it is just as revolutionary. Renovare Therapeutics was launched by way of a $33.5 million award from the Advanced Research Projects Agency for Health (ARPA-H), a defining investment in a new generation of regenerative med icine awarded to Renovare Therapeutics’ partner, University of Colorado Boulder. Awarded through ARPA-H’s Novel Innovations for Tissue Regeneration in Osteoarthritis (NITRO) program, the funding unites decades of pioneering research, world-class expertise, and a shared vision into a company built to rede fine osteoarthritis treatment. NITRO was created to move moonshot concepts from the laboratory to phase 1 clinical studies within five years, redefining the speed at which therapies can reach patients. The technology’s potential made interna tional headlines. Building on more than 25 years of research in tissue engineering and regenerative medicine, Renovare Therapeutics’ portfolio is centered on controlled drug delivery, gene therapy, and advanced biomaterials. Renovare Therapeutics showcases the power of Colorado’s innovation eco system, bringing together more than 50 researchers from CU Boulder (Stephanie Bryant, Ph.D., Lead Principal Investigator), the University of Colorado Anschutz Medical Campus (Mike Zuscik, Ph.D., and Karin Payne, Ph.D., Co-Principal Investigators), and Colorado State University (Laurie Goodrich, Ph.D., Co-Principal Investigator), as well as rapid commercialization expertise from Venture Partners at CU Boulder. “When this opportunity came along, we weren’t building a team from scratch,” says Stephanie Bryant, Ph.D., Renovare Therapeutics’ Chief Scientific Officer. “We were bringing together people who had already been collaborating.” The progress is striking. In two years, the team advanced six potential prod ucts from idea to proof of concept, with two therapies demonstrating complete cartilage regeneration following a single administration in preclinical animal models. Those programs are now moving into IND-enabling studies to be followed by phase 1 clinical trials. More than 2,000 patients have already expressed interest in participating in future clinical trials. After building companies in Silicon Valley, Scott found something fundamentally dif ferent in Colorado. “People genuinely want to help each other succeed,” Scott says. “It’s collaborative “ There’s nothing but opportunity here. L I Z S CO T T, M . B. A . C E O R E N OVA R E T H E R A P E U T I C S I Images on previous page: Research conducted on the NITRO award is a collaboration among CU Boulder, CU Anschutz, and CSU. Shown left to right: CU Boulder’s Stephanie Bryant, Ph.D., lead Principal Investigator (PI); CU Anschutz’s Mike Zuscik, Ph.D., and Karin Payne, Ph.D., co-PIs; and CSU’s Laurie Goodrich, Ph.D., co-PI. Stephanie Bryant, Ph.D., works with Laurel Stefani, a biomedical engineering doctoral candidate from Richardson, Texas. rather than cutthroat, and organizations like Colorado BioScience Association, Innosphere, Rockies Venture Club, and our research institutions create a place where mentorship, partnership, and inno vation happen naturally. There’s nothing but opportunity here.” 2026-27 BIOSCIENCE COLORADO 19
View this content as a flipbook by clicking here.